Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Benjamin Steinberg

Concepts (410)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Atrial Fibrillation
128
2026
555
30.290
 Why?
Anticoagulants
50
2026
729
8.660
 Why?
Anti-Arrhythmia Agents
24
2026
141
6.350
 Why?
Stroke
36
2025
1262
5.810
 Why?
Catheter Ablation
25
2025
354
5.580
 Why?
Registries
37
2025
2392
3.840
 Why?
Heart Failure
28
2025
2324
3.710
 Why?
Patient Reported Outcome Measures
16
2024
496
3.690
 Why?
Warfarin
15
2023
173
3.270
 Why?
Heart Rate
15
2026
853
2.660
 Why?
Electrocardiography, Ambulatory
4
2024
63
2.630
 Why?
Sotalol
8
2025
13
2.470
 Why?
Hemorrhage
22
2026
813
2.460
 Why?
Defibrillators, Implantable
12
2025
381
2.380
 Why?
Thromboembolism
8
2019
126
2.340
 Why?
Aged
101
2026
25955
2.180
 Why?
Electric Countershock
8
2022
127
2.000
 Why?
Treatment Outcome
61
2026
11735
1.900
 Why?
Risk Assessment
29
2026
3729
1.900
 Why?
Cardiac Resynchronization Therapy
5
2022
63
1.690
 Why?
Stroke Volume
13
2025
650
1.670
 Why?
Amiodarone
5
2025
31
1.650
 Why?
Administration, Oral
21
2026
851
1.600
 Why?
Humans
173
2026
144671
1.600
 Why?
Coronary Artery Disease
10
2023
743
1.460
 Why?
Risk Factors
46
2026
10796
1.450
 Why?
Male
114
2026
72431
1.430
 Why?
Wearable Electronic Devices
3
2023
62
1.410
 Why?
Female
115
2026
78304
1.400
 Why?
Pacemaker, Artificial
5
2024
126
1.350
 Why?
Electrocardiography
10
2024
664
1.340
 Why?
Atrial Flutter
4
2026
47
1.300
 Why?
Middle Aged
73
2026
35971
1.300
 Why?
Aged, 80 and over
40
2026
8284
1.180
 Why?
Electrophysiologic Techniques, Cardiac
6
2024
82
1.170
 Why?
Quality of Life
14
2024
3183
1.160
 Why?
Atrial Appendage
3
2025
36
1.110
 Why?
Time Factors
25
2026
7140
1.050
 Why?
Disease Management
4
2020
650
1.020
 Why?
Arrhythmias, Cardiac
6
2024
355
1.020
 Why?
Practice Patterns, Physicians'
4
2025
1360
1.020
 Why?
Cardiac Electrophysiology
3
2024
21
1.000
 Why?
United States
36
2026
16018
0.990
 Why?
beta-Alanine
4
2014
24
0.990
 Why?
Vitamin K
5
2017
45
0.960
 Why?
Follow-Up Studies
20
2025
5414
0.940
 Why?
Prospective Studies
26
2025
7994
0.940
 Why?
Benzimidazoles
4
2014
187
0.910
 Why?
Comorbidity
13
2024
1652
0.900
 Why?
Utah
8
2026
80
0.890
 Why?
Bundle-Branch Block
2
2023
36
0.890
 Why?
Electric Power Supplies
1
2025
48
0.870
 Why?
Heart Atria
6
2024
141
0.830
 Why?
Cardiac Resynchronization Therapy Devices
3
2021
18
0.820
 Why?
Tricuspid Valve
1
2024
42
0.820
 Why?
Retrospective Studies
34
2026
17149
0.810
 Why?
Bundle of His
1
2023
19
0.800
 Why?
Heart Valve Prosthesis
2
2024
129
0.770
 Why?
Lithotripsy
1
2023
49
0.760
 Why?
Pyroptosis
1
2022
5
0.760
 Why?
Tachycardia, Paroxysmal
1
2022
8
0.740
 Why?
Survival Rate
11
2021
2089
0.720
 Why?
Coronary Artery Bypass
4
2013
267
0.700
 Why?
Rivaroxaban
4
2017
268
0.690
 Why?
Glycine
1
2022
186
0.690
 Why?
Cardiac Pacing, Artificial
5
2024
84
0.690
 Why?
Embolism
3
2021
48
0.680
 Why?
Heart Conduction System
3
2023
96
0.680
 Why?
Factor Xa Inhibitors
6
2020
187
0.680
 Why?
Hospitalization
10
2025
2446
0.660
 Why?
Patient Discharge
3
2024
985
0.660
 Why?
Scholarly Communication
1
2020
4
0.660
 Why?
Peer Influence
1
2020
14
0.650
 Why?
Decision Support Techniques
4
2025
461
0.610
 Why?
Clinical Trials as Topic
3
2024
1056
0.610
 Why?
Incidence
12
2025
2892
0.610
 Why?
Self-Assessment
1
2020
75
0.600
 Why?
Morpholines
3
2014
129
0.590
 Why?
Thiophenes
3
2014
121
0.590
 Why?
Workload
1
2020
167
0.570
 Why?
Myocardial Infarction
5
2019
1209
0.560
 Why?
Death, Sudden, Cardiac
2
2017
230
0.550
 Why?
Checklist
1
2019
111
0.540
 Why?
Pyridones
2
2017
201
0.540
 Why?
Dabigatran
5
2017
29
0.530
 Why?
Social Media
1
2020
167
0.520
 Why?
Length of Stay
4
2024
1339
0.510
 Why?
Biomedical Research
2
2021
712
0.510
 Why?
Brain Ischemia
2
2018
358
0.500
 Why?
Health Status
2
2020
834
0.500
 Why?
Heart Failure, Systolic
1
2017
27
0.490
 Why?
Off-Label Use
1
2016
51
0.490
 Why?
Blood Component Transfusion
1
2017
104
0.470
 Why?
Nervous System
1
2016
69
0.460
 Why?
Pyrazoles
2
2017
512
0.460
 Why?
Heparin, Low-Molecular-Weight
1
2015
36
0.450
 Why?
Infusions, Intravenous
3
2026
422
0.450
 Why?
Therapy, Computer-Assisted
1
2015
64
0.440
 Why?
Eligibility Determination
1
2015
72
0.440
 Why?
Medicare
7
2022
899
0.430
 Why?
American Heart Association
2
2017
356
0.430
 Why?
Ventricular Function, Left
2
2022
536
0.430
 Why?
Dementia
3
2025
319
0.430
 Why?
Cardiac Imaging Techniques
1
2014
24
0.420
 Why?
Critical Pathways
2
2013
108
0.420
 Why?
Practice Guidelines as Topic
6
2024
1569
0.410
 Why?
Cardiovascular Diseases
7
2024
2172
0.410
 Why?
Elective Surgical Procedures
1
2015
201
0.400
 Why?
Cardiomyopathies
1
2017
334
0.400
 Why?
Intracranial Hemorrhages
1
2014
101
0.400
 Why?
Electronic Health Records
5
2024
1176
0.400
 Why?
Blood Coagulation
1
2015
269
0.390
 Why?
Drug Administration Schedule
6
2020
779
0.390
 Why?
Guideline Adherence
3
2019
586
0.390
 Why?
Platelet Aggregation Inhibitors
4
2024
496
0.390
 Why?
Cerebral Hemorrhage
1
2014
120
0.390
 Why?
Gastrointestinal Hemorrhage
1
2014
136
0.380
 Why?
Predictive Value of Tests
8
2024
2117
0.370
 Why?
Dose-Response Relationship, Drug
5
2024
2019
0.370
 Why?
Antithrombins
4
2017
69
0.370
 Why?
Drug Dosage Calculations
3
2018
27
0.370
 Why?
Prognosis
10
2025
4312
0.360
 Why?
Natural Language Processing
4
2023
103
0.350
 Why?
Angioplasty, Balloon, Coronary
3
2007
155
0.350
 Why?
Critical Care
3
2016
695
0.350
 Why?
Hospitals, University
1
2012
176
0.350
 Why?
Proportional Hazards Models
6
2021
1322
0.350
 Why?
Prevalence
8
2025
2839
0.340
 Why?
Randomized Controlled Trials as Topic
8
2024
1742
0.340
 Why?
Action Potentials
6
2025
502
0.340
 Why?
Patient Selection
1
2015
727
0.330
 Why?
Heart Valve Prosthesis Implantation
2
2013
197
0.330
 Why?
Global Health
3
2019
401
0.320
 Why?
Hemodynamics
2
2026
1113
0.320
 Why?
Multivariate Analysis
6
2021
1537
0.320
 Why?
Valine
2
2021
80
0.320
 Why?
Echocardiography, Transesophageal
3
2017
132
0.320
 Why?
Age Factors
8
2025
3329
0.310
 Why?
Brain
1
2022
2934
0.310
 Why?
Aspirin
1
2013
402
0.310
 Why?
Triage
1
2012
249
0.300
 Why?
Aortic Valve Stenosis
1
2012
255
0.300
 Why?
Outpatients
3
2020
447
0.290
 Why?
Cause of Death
5
2024
464
0.290
 Why?
Fibrinolytic Agents
2
2013
290
0.290
 Why?
Heart Diseases
1
2012
341
0.290
 Why?
Hemostasis
2
2022
98
0.290
 Why?
Recovery of Function
3
2024
715
0.280
 Why?
Patient Readmission
1
2014
765
0.270
 Why?
Periodicals as Topic
2
2021
206
0.270
 Why?
Atrial Function, Left
2
2024
9
0.270
 Why?
Cost-Benefit Analysis
2
2024
638
0.270
 Why?
Body Mass Index
2
2025
2419
0.270
 Why?
Clinical Decision-Making
2
2021
360
0.260
 Why?
Physicians
1
2016
949
0.260
 Why?
Diagnosis, Computer-Assisted
2
2020
91
0.260
 Why?
Logistic Models
5
2021
2114
0.260
 Why?
Multicenter Studies as Topic
5
2024
408
0.260
 Why?
Myocardial Reperfusion
1
2007
57
0.260
 Why?
Cognition
3
2025
1263
0.250
 Why?
Administration, Intravenous
2
2025
170
0.250
 Why?
Enoxaparin
1
2007
68
0.240
 Why?
Sensitivity and Specificity
4
2020
1995
0.240
 Why?
Propanolamines
2
2017
40
0.240
 Why?
Voltage-Gated Sodium Channel Blockers
1
2026
7
0.240
 Why?
Patient Participation
4
2025
428
0.230
 Why?
Adult
13
2025
40489
0.230
 Why?
Lidocaine
1
2026
54
0.230
 Why?
Severity of Illness Index
4
2024
2922
0.230
 Why?
Cardiovascular Agents
1
2007
165
0.220
 Why?
Sleep Apnea, Obstructive
2
2020
300
0.220
 Why?
Equipment Failure
1
2025
115
0.220
 Why?
Inflammation
1
2016
2870
0.210
 Why?
Hospital Mortality
4
2026
1033
0.210
 Why?
Perioperative Care
3
2016
231
0.210
 Why?
Tachycardia, Supraventricular
1
2024
45
0.200
 Why?
Disease Progression
5
2022
2847
0.200
 Why?
Fee-for-Service Plans
2
2014
99
0.200
 Why?
Ambulatory Surgical Procedures
1
2024
79
0.200
 Why?
Cluster Analysis
2
2022
516
0.200
 Why?
Chi-Square Distribution
2
2015
524
0.200
 Why?
Cohort Studies
8
2021
5957
0.200
 Why?
Hospital Costs
1
2024
125
0.200
 Why?
Equipment Design
1
2025
527
0.200
 Why?
Postoperative Complications
4
2025
2950
0.190
 Why?
Quality Improvement
1
2012
1287
0.190
 Why?
Observational Studies as Topic
2
2014
131
0.190
 Why?
Physicians, Women
1
2024
88
0.190
 Why?
Macular Degeneration
1
2025
190
0.190
 Why?
Symptom Assessment
1
2024
136
0.190
 Why?
Cell Adhesion Molecules, Neuronal
1
2022
42
0.190
 Why?
Adonis
1
2022
1
0.190
 Why?
Cicatrix
2
2020
69
0.190
 Why?
Nerve Growth Factors
1
2022
78
0.180
 Why?
Brain Infarction
1
2022
23
0.180
 Why?
Medication Adherence
2
2019
540
0.180
 Why?
Time-to-Treatment
1
2024
242
0.180
 Why?
Esophageal Fistula
1
2022
21
0.180
 Why?
Magnetic Resonance Imaging
4
2020
3888
0.180
 Why?
Diabetes Mellitus
2
2022
1076
0.180
 Why?
Hypertension
3
2023
1262
0.180
 Why?
Ablation Techniques
2
2019
36
0.180
 Why?
Remote Sensing Technology
1
2022
19
0.180
 Why?
Prosthesis Design
1
2024
355
0.180
 Why?
Obesity
2
2025
3070
0.180
 Why?
Patient Preference
1
2024
226
0.180
 Why?
Fistula
1
2022
49
0.170
 Why?
Health Equity
1
2024
132
0.170
 Why?
Artificial Intelligence
2
2023
381
0.170
 Why?
Cardiac Catheterization
2
2020
557
0.170
 Why?
Inflammasomes
1
2022
145
0.170
 Why?
Perfusion
1
2022
249
0.170
 Why?
Thoracic Injuries
1
2022
71
0.170
 Why?
Disaccharides
1
2021
21
0.170
 Why?
Lactams
1
2021
28
0.170
 Why?
Cell Death
1
2022
382
0.170
 Why?
Societies, Medical
2
2017
890
0.170
 Why?
Research Report
1
2021
86
0.160
 Why?
Gadolinium
4
2022
84
0.160
 Why?
Receptors, Adrenergic, beta-1
2
2017
24
0.160
 Why?
Transgender Persons
1
2024
207
0.160
 Why?
Adiposity
1
2025
529
0.160
 Why?
Contrast Media
5
2022
492
0.160
 Why?
Esophagus
2
2022
262
0.160
 Why?
Health Services
1
2021
114
0.160
 Why?
Authorship
1
2020
49
0.160
 Why?
Contraindications, Drug
1
2019
10
0.150
 Why?
Kidney
2
2020
1495
0.150
 Why?
Social Class
1
2021
265
0.150
 Why?
HMGB1 Protein
1
2019
51
0.150
 Why?
Monitoring, Physiologic
1
2021
288
0.140
 Why?
Cell Membrane
1
2022
706
0.140
 Why?
Social Determinants of Health
1
2023
305
0.140
 Why?
DNA Demethylation
1
2018
4
0.140
 Why?
Esophageal Diseases
1
2018
30
0.140
 Why?
Telemetry
1
2018
40
0.140
 Why?
Feasibility Studies
2
2020
1103
0.140
 Why?
Natriuretic Peptide, Brain
1
2018
109
0.130
 Why?
Ventricular Dysfunction, Left
1
2021
392
0.130
 Why?
Metoprolol
1
2017
26
0.130
 Why?
Computer Systems
1
2017
55
0.130
 Why?
Sex Factors
2
2021
2104
0.130
 Why?
Drug Substitution
2
2017
63
0.130
 Why?
Evidence-Based Medicine
2
2021
732
0.130
 Why?
North Carolina
2
2014
126
0.130
 Why?
Recurrence
4
2024
1136
0.130
 Why?
Defibrillators
1
2017
23
0.130
 Why?
Reproducibility of Results
4
2020
3414
0.120
 Why?
Venous Thromboembolism
1
2021
326
0.120
 Why?
Choline O-Acetyltransferase
1
2016
26
0.120
 Why?
Nervous System Diseases
1
2020
285
0.120
 Why?
Hemostatic Techniques
1
2017
52
0.120
 Why?
Tertiary Care Centers
1
2017
194
0.120
 Why?
Data Collection
1
2019
635
0.120
 Why?
Hypertrophy, Left Ventricular
2
2015
122
0.120
 Why?
Reflex
1
2016
70
0.120
 Why?
Kaplan-Meier Estimate
2
2018
967
0.120
 Why?
Drug Prescriptions
1
2018
283
0.110
 Why?
Contraindications
1
2015
90
0.110
 Why?
Adrenergic beta-Antagonists
2
2015
251
0.110
 Why?
Hospitals, Community
1
2015
66
0.110
 Why?
Percutaneous Coronary Intervention
1
2020
547
0.100
 Why?
Blood Pressure
2
2023
1766
0.100
 Why?
Renal Insufficiency, Chronic
1
2021
657
0.100
 Why?
Intention to Treat Analysis
1
2014
79
0.100
 Why?
Odds Ratio
2
2013
1076
0.100
 Why?
Surveys and Questionnaires
2
2024
6041
0.100
 Why?
Emergencies
1
2015
175
0.100
 Why?
Cardiology
1
2017
359
0.100
 Why?
Animals
7
2022
37948
0.100
 Why?
Ventilator-Induced Lung Injury
1
2014
61
0.100
 Why?
Premedication
1
2013
44
0.100
 Why?
Double-Blind Method
2
2017
2033
0.100
 Why?
Ischemic Attack, Transient
1
2014
71
0.100
 Why?
Epigenesis, Genetic
1
2018
669
0.100
 Why?
Ticlopidine
1
2013
51
0.100
 Why?
Coronary Disease
2
2006
381
0.100
 Why?
Gene Expression Regulation, Developmental
1
2018
906
0.100
 Why?
Accreditation
1
2013
101
0.100
 Why?
Quality of Health Care
2
2019
692
0.090
 Why?
Thrombosis
1
2017
396
0.090
 Why?
Primary Prevention
1
2014
217
0.090
 Why?
Drug Synergism
1
2013
352
0.090
 Why?
Operating Rooms
1
2014
143
0.090
 Why?
Cerebrovascular Disorders
1
2013
106
0.090
 Why?
Calcium Channel Blockers
1
2013
165
0.090
 Why?
Peripheral Arterial Disease
1
2019
504
0.090
 Why?
Models, Cardiovascular
1
2013
193
0.090
 Why?
Electronics
2
2023
69
0.090
 Why?
Atrioventricular Block
1
2012
44
0.090
 Why?
Critical Illness
1
2018
888
0.090
 Why?
Ventricular Remodeling
1
2014
275
0.090
 Why?
Cross-Sectional Studies
2
2021
5870
0.090
 Why?
Clinical Trials, Phase II as Topic
2
2024
76
0.090
 Why?
Myocardial Ischemia
1
2013
285
0.090
 Why?
Depression
1
2021
1561
0.080
 Why?
Diagnostic Imaging
1
2014
341
0.080
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2013
259
0.080
 Why?
Continuity of Patient Care
1
2013
293
0.080
 Why?
Risk
1
2013
911
0.080
 Why?
International Normalized Ratio
2
2021
52
0.080
 Why?
CD4-Positive T-Lymphocytes
1
2016
1129
0.080
 Why?
Glomerular Filtration Rate
1
2013
764
0.080
 Why?
Kidney Diseases
1
2013
427
0.080
 Why?
Mice
3
2022
18261
0.070
 Why?
Liver
1
2018
1889
0.070
 Why?
Respiration, Artificial
1
2014
710
0.070
 Why?
Socioeconomic Factors
1
2013
1322
0.070
 Why?
Patient Education as Topic
1
2013
771
0.070
 Why?
Databases, Factual
2
2025
1494
0.060
 Why?
Retreatment
1
2007
77
0.060
 Why?
Referral and Consultation
1
2013
852
0.060
 Why?
Thinness
1
2025
98
0.060
 Why?
Health Knowledge, Attitudes, Practice
1
2013
1406
0.050
 Why?
Signal Transduction
1
2018
5185
0.050
 Why?
Cardiologists
1
2024
47
0.050
 Why?
Pragmatic Clinical Trials as Topic
1
2024
133
0.050
 Why?
Drug Therapy, Combination
2
2019
1044
0.050
 Why?
Tomography, X-Ray Computed
1
2014
2754
0.050
 Why?
Gender Identity
1
2024
126
0.050
 Why?
Magnetic Resonance Imaging, Cine
1
2024
213
0.050
 Why?
Syncope
1
2023
56
0.050
 Why?
Echocardiography
1
2025
644
0.050
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2006
438
0.050
 Why?
Vena Cava, Superior
1
2022
25
0.040
 Why?
Dizziness
1
2023
101
0.040
 Why?
Career Choice
1
2024
233
0.040
 Why?
Mentors
1
2024
214
0.040
 Why?
Flecainide
1
2021
8
0.040
 Why?
Reoperation
1
2024
624
0.040
 Why?
Age of Onset
1
2023
551
0.040
 Why?
Dyspnea
1
2023
250
0.040
 Why?
Peptide Fragments
1
2005
691
0.040
 Why?
Chicago
1
2020
62
0.040
 Why?
Device Removal
1
2022
142
0.040
 Why?
Psychometrics
1
2024
731
0.040
 Why?
Atrial Remodeling
1
2020
10
0.040
 Why?
Current Procedural Terminology
1
2020
19
0.040
 Why?
Seasons
1
2023
556
0.040
 Why?
Meglumine
1
2020
18
0.040
 Why?
Emergency Service, Hospital
1
2012
2325
0.040
 Why?
Aftercare
1
2022
222
0.040
 Why?
Cells, Cultured
2
2018
4110
0.040
 Why?
Temperature
1
2023
680
0.040
 Why?
Intracranial Embolism
1
2019
34
0.040
 Why?
Phenotype
2
2018
3147
0.040
 Why?
Forecasting
1
2021
391
0.040
 Why?
Heart
1
2023
626
0.040
 Why?
Education, Medical, Graduate
1
2024
562
0.040
 Why?
Propensity Score
1
2021
373
0.040
 Why?
International Classification of Diseases
1
2020
147
0.040
 Why?
Myocardial Revascularization
1
2019
84
0.040
 Why?
Peripheral Vascular Diseases
1
2019
104
0.040
 Why?
Hyperlipidemias
1
2019
120
0.040
 Why?
Organometallic Compounds
1
2020
113
0.040
 Why?
Support Vector Machine
1
2018
33
0.040
 Why?
Kidney Failure, Chronic
1
2005
597
0.040
 Why?
Peripheral Nervous System Diseases
1
2019
133
0.040
 Why?
5-Methylcytosine
1
2018
24
0.030
 Why?
Dioxygenases
1
2018
36
0.030
 Why?
Self-Management
1
2021
201
0.030
 Why?
Adrenergic alpha-1 Receptor Antagonists
1
2017
18
0.030
 Why?
Patient Safety
1
2021
353
0.030
 Why?
Asymptomatic Diseases
1
2018
103
0.030
 Why?
Consensus
1
2020
475
0.030
 Why?
Diffusion of Innovation
1
2018
95
0.030
 Why?
Primary Cell Culture
1
2018
172
0.030
 Why?
Clinical Trials, Phase III as Topic
1
2017
116
0.030
 Why?
Systole
1
2017
177
0.030
 Why?
Models, Biological
1
2025
1811
0.030
 Why?
Hepatocytes
1
2018
221
0.030
 Why?
Cognitive Dysfunction
1
2023
464
0.030
 Why?
ROC Curve
1
2018
618
0.030
 Why?
Mortality
1
2019
377
0.030
 Why?
Feedback, Physiological
1
2016
81
0.030
 Why?
Mice, Inbred C57BL
2
2018
5967
0.030
 Why?
Longitudinal Studies
1
2023
2942
0.030
 Why?
Sequence Analysis, RNA
1
2018
442
0.030
 Why?
Animals, Newborn
1
2018
890
0.030
 Why?
Proto-Oncogene Proteins
1
2018
619
0.030
 Why?
Genetic Testing
1
2017
480
0.030
 Why?
Patient Satisfaction
1
2019
707
0.030
 Why?
High-Throughput Nucleotide Sequencing
1
2018
552
0.030
 Why?
Decision Making
1
2022
973
0.030
 Why?
District of Columbia
1
2014
37
0.030
 Why?
Pandemics
1
2022
1700
0.030
 Why?
Pharmacogenetics
1
2015
172
0.030
 Why?
Abdomen
1
2014
141
0.020
 Why?
Internship and Residency
1
2024
1262
0.020
 Why?
Costs and Cost Analysis
1
2014
221
0.020
 Why?
Genotype
1
2017
1847
0.020
 Why?
Machine Learning
1
2018
587
0.020
 Why?
Polymorphism, Genetic
1
2015
613
0.020
 Why?
Insurance Coverage
1
2014
243
0.020
 Why?
Ambulatory Care
1
2016
607
0.020
 Why?
Mice, Knockout
1
2018
3109
0.020
 Why?
DNA
1
2017
1447
0.020
 Why?
DNA-Binding Proteins
1
2018
1484
0.020
 Why?
Rats
1
2019
5570
0.020
 Why?
Patient Compliance
1
2014
587
0.020
 Why?
Genetic Predisposition to Disease
1
2018
2350
0.020
 Why?
Disease Models, Animal
1
2019
4539
0.020
 Why?
Young Adult
1
2024
14122
0.020
 Why?
Biomarkers
1
2018
4261
0.020
 Why?
Syndrome
1
2006
379
0.010
 Why?
Hirudins
1
2005
51
0.010
 Why?
Adolescent
1
2024
22409
0.010
 Why?
Kidney Function Tests
1
2005
156
0.010
 Why?
Creatinine
1
2005
509
0.010
 Why?
Recombinant Proteins
1
2005
1363
0.010
 Why?
Steinberg's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (410) concept(s)
_
Co-Authors Expand Description
See all (6) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)